Cargando…
Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study
The use of high dose ascorbate infusions in cancer patients is widespread, but without evidence of efficacy. Several mechanisms whereby ascorbate could affect tumor progression have been proposed, including: (i) the localized generation of cytotoxic quantities of H(2)O(2); (ii) ascorbate-dependent a...
Autores principales: | Dachs, Gabi U., Gandhi, Jamish, Wohlrab, Christina, Carr, Anitra C., Morrin, Helen R., Pullar, Juliet M., Bayer, Simone B., Eglinton, Tim W., Robinson, Bridget A., Vissers, Margreet C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830882/ https://www.ncbi.nlm.nih.gov/pubmed/33505915 http://dx.doi.org/10.3389/fonc.2020.600715 |
Ejemplares similares
-
Erythrocyte Ascorbate Is a Potential Indicator of Steady-State Plasma Ascorbate Concentrations in Healthy Non-Fasting Individuals
por: M. Pullar, Juliet, et al.
Publicado: (2020) -
The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
por: Wohlrab, Christina, et al.
Publicado: (2018) -
Marginal Ascorbate Status (Hypovitaminosis C) Results in an Attenuated Response to Vitamin C Supplementation
por: Carr, Anitra C., et al.
Publicado: (2016) -
Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells
por: Wohlrab, Christina, et al.
Publicado: (2019) -
Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels
por: Campbell, Elizabeth J., et al.
Publicado: (2019)